$23.00
At close: Aug 17, 5:00 PM EST
$23.00
N/A
After Hours: Aug 14, 4:00 PM EST
Pacira BioSciences Inc Earnings Estimates
PCRXNASDAQ
Pacira BioSciences Earnings Estimates, EPS & Revenue | NASDAQ:PCRX
Pacira BioSciences (PCRX) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $0.69 and quarterly revenue of $182.47M.
In the most recent quarter (Q2), Pacira BioSciences reported EPS of $0.73, beating estimates of $0.57 by 0.28%. Revenue came in at $192.4M, exceeding the estimate of $190.89M by 0.01%.
Pacira BioSciences has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Pacira BioSciences has averaged an EPS surprise of 0.24% and a revenue surprise of 0.01%.
Earnings Date
Nov 5
EPS Estimate
$0.690
Quarterly Revenue Estimate
$182.47M
Annual Revenue
$746.16M
as of Jun 30
Pacira BioSciences Earnings History
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Pacira BioSciences (PCRX) Earnings Per Share
The chart below shows Pacira BioSciences's reported EPS compared to analyst estimates over recent quarters.
Pacira BioSciences (PCRX) Revenue
The chart below shows Pacira BioSciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Pacira BioSciences (NASDAQ:PCRX) reporting earnings?
Pacira BioSciences (PCRX) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 4, 2026 for Q2.
What were the latest earnings per share (EPS) for Pacira BioSciences (NASDAQ:PCRX)?
The Actual EPS was $0.73, which beat the estimate of $0.57.
What were Pacira BioSciences’s (NASDAQ:PCRX) revenues?
The Actual Revenue was $192.4M, which beat the estimate of $190.89M.
